In Vitro Efficient Transfection by CM18-Tat11 Hybrid Peptide: A New Tool for Gene-Delivery Applications

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Salomone, Fabrizio ^a,b   Cardarelli, Francesco ^b   Signore, Giovanni ^b   Boccardi, Claudia ^b   Beltram, Fabio ^a,b  

^a SCUOLA NORMALE SUPERIORE   (Italy)

^b CENTER FOR NANOTECHNOLOGY INNOVATION NEST   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CECROPIN A; CELL PENETRATING PEPTIDE; DNA; LUCIFERASE; LYSYLTRYPTOPHYLLYSYLLEUCYLPHENYLALANYLLYSYLLYSYLISOLEUCYLGLYCYLALANYLVALYLLEUCYLLYSYLVALYLLEUCYLTHREONYLTHREONYLGLYCYLTYROSYLGLYCYLARGINYLLYSYLLYSYLARGINYLARGINYLGLUTAMINYLARGINYLARGINYLARGININE; MELITTIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL TRANSPORT; CELL VACUOLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DNA TRANSFECTION; ENDOCYTOSIS; ENDOSOME; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENE VECTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PROTEIN DNA INTERACTION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REPORTER GENE; STOICHIOMETRY;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL-PENETRATING PEPTIDES; DNA; ENDOSOMES; GENE TRANSFER TECHNIQUES; HUMANS; MOLECULAR IMAGING; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSFECTION;

EID: 84880797054     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070108     Document Type: Article

References (41)

1. Luo D, Saltzman WM, (2000) Synthetic DNA delivery systems. Nat Biotechnol 18: 33-37. doi:10.1038/71889. PubMed: 10625387.
2. Kay MA, Glorioso JC, Naldini L, (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7: 33-40. doi:10.1038/83324. PubMed: 11135613.
3. Warnock JN, Daigre C, Al-Rubeai M, (2011) Introduction to viral vectors. Methods Mol Biol 737: 1-25. doi:10.1007/978-1-61779-095-9_1. PubMed: 21590391.
4. Thomas CE, Ehrhardt A, Kay MA, (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4: 346-358. doi:10.1038/nrg1066. PubMed: 12728277.
5. Viola JR, El-Andaloussi S, Oprea II, Smith CI, (2010) Non-viral nanovectors for gene delivery: factors that govern successful therapeutics. Expert Opin Drug Deliv 7: 721-735. doi:10.1517/17425241003716810. PubMed: 20367531.
6. Jo J, Tabata Y, (2008) Non-viral gene transfection technologies for genetic engineering of stem cells. Eur J Pharm Biopharm 68: 90-104. doi:10.1016/j.ejpb.2007.04.021. PubMed: 17870447.
7. Li S, Huang L, (2000) Nonviral gene therapy: promises and challenges. Gene Ther 7: 31-34. doi:10.1038/sj.gt.3301110. PubMed: 10680013.
8. Pack DW, Hoffman AS, Pun S, Stayton PS, (2005) Design and development of polymers for gene delivery. Nat Rev Drug Discov 4: 581-593. doi:10.1038/nrd1775. PubMed: 16052241.
9. Petros RA, DeSimone JM, (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9: 615-627. doi:10.1038/nrd2591. PubMed: 20616808.
10. Bolhassani A, (2011) Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim Biophys Acta 1816: 232-246. PubMed: 21840374.
11. Glover DJ, Lipps HJ, Jans DA, (2005) Towards safe, non-viral therapeutic gene expression in humans. Nat Rev Genet 6: 299-310. doi:10.1038/nrg1577. PubMed: 15761468.
12. Nakase I, Akita H, Kogure K, Gräslund A, Langel U, et al. (2012) Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Acc Chem Res 45: 1132-1139. doi:10.1021/ar200256e. PubMed: 22208383.
13. Lehto T, Simonson OE, Mäger I, Ezzat K, Sork H, et al. (2011) A peptide-based vector for efficient gene transfer in vitro and in vivo. Mol Ther 19: 1457-1467. doi:10.1038/mt.2011.10. PubMed: 21343913.
14. Ignatovich IA, Dizhe EB, Pavlotskaya AV, Akifiev BN, Burov SV, et al. (2003) Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J Biol Chem 278: 42625-42636. doi:10.1074/jbc.M301431200. PubMed: 12882958.
15. Liu Z, Li M, Cui D, Fei J, (2005) Macro-branched cell-penetrating peptide design for gene delivery. J Control Release 102: 699-710. doi:10.1016/j.jconrel.2004.10.013. PubMed: 15681091.
16. Mäe M, El Andaloussi S, Lundin P, Oskolkov N, Johansson HJ, et al. (2008) A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy. J Control Release 134: 221-227. PubMed: 19105971.
17. Liu BR, Lin MD, Chiang HJ, Lee HJ, (2012) Arginine-rich cell-penetrating peptides deliver gene into living human cells. Gene 505: 37-45. doi:10.1016/j.gene.2012.05.053. PubMed: 22669044.
18. Yi WJ, Yang J, Li C, Wang HY, Liu CW, et al. (2012) Enhanced nuclear import and transfection efficiency of TAT peptide-based gene delivery systems modified by additional nuclear localization signals. Bioconjug Chem 23: 125-134. doi:10.1021/bc2005472. PubMed: 22148643.
19. Hoyer J, Neundorf I, (2012) Peptide vectors for the nonviral delivery of nucleic acids. Acc Chem Res 45: 1048-1056. doi:10.1021/ar2002304. PubMed: 22455499.
20. Salomone F, Cardarelli F, Di Luca M, Boccardi C, Nifosì R, et al. (2012) A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. J Control Release 163: 293-303. doi:10.1016/j.jconrel.2012.09.019. PubMed: 23041543.
21. Sato H, Feix JB, (2006) Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides. Biochim Biophys Acta 1758: 1245-1256. doi:10.1016/j.bbamem.2006.02.021. PubMed: 16697975.
22. Meade BR, Dowdy SF, (2008) Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev 60: 530-536. doi:10.1016/j.addr.2007.10.004. PubMed: 18155315.
23. Deshayes S, Morris M, Heitz F, Divita G, (2008) Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv Drug Deliv Rev 60: 537-547. doi:10.1016/j.addr.2007.09.005. PubMed: 18037526.
24. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, et al. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97: 13003-13008. doi:10.1073/pnas.97.24.13003. PubMed: 11087855.
25. Lundin P, Johansson H, Guterstam P, Holm T, Hansen M, et al. (2008) Distinct uptake routes of cell-penetrating peptide conjugates. Bioconjug Chem 19: 2535-2542. doi:10.1021/bc800212j. PubMed: 19012426.
26. Erazo-Oliveiras A, Muthukrishnan N, Baker R, Wang T, Pellois J, (2012) Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals 5: 1177-1209.
27. Cardarelli F, Serresi M, Bizzarri R, Beltram F, (2008) Tuning the transport properties of HIV-1 Tat arginine-rich motif in living cells. Traffic 9: 528-539. doi:10.1111/j.1600-0854.2007.00696.x. PubMed: 18182009.
28. Gooding M, Browne LP, Quinteiro FM, Selwood DL, (2012) siRNA delivery: from lipids to cell-penetrating peptides and their mimics. Chem Biol Drugs Des 80: 787-809. doi:10.1111/cbdd.12052. PubMed: 22974319.
29. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ, (1995) Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 270: 18997-19007. doi:10.1074/jbc.270.32.18997. PubMed: 7642560.
30. Cardarelli F, Pozzi D, Bifone A, Marchini C, Caracciolo G, (2012) Cholesterol-dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO living cells. Mol Pharm 9: 334-340. doi:10.1021/mp200374e. PubMed: 22196199.
31. Pozzi D, Marchini C, Cardarelli F, Amenitsch H, Garulli C, et al. (2012) Transfection efficiency boost of cholesterol-containing lipoplexes. Biochim Biophys Acta 1818: 2335-2343. doi:10.1016/j.bbamem.2012.05.017. PubMed: 22627109.
32. Coonrod A, Li FQ, Horwitz M, (1997) On the mechanism of DNA transfection: efficient gene transfer without viruses. Gene Ther 4: 1313-1321. doi:10.1038/sj.gt.3300536. PubMed: 9472555.
33. James MB, Giorgio TD, (2000) Nuclear-associated plasmid, but not cell-associated plasmid, is correlated with transgene expression in cultured mammalian cells. Mol Ther 1: 339-346. doi:10.1006/mthe.2000.0054. PubMed: 10933952.
34. Tseng WC, Haselton FR, Giorgio TD, (1997) Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. J Biol Chem 272: 25641-25647. doi:10.1074/jbc.272.41.25641. PubMed: 9325286.
35. Ludtke JJ, Sebestyén MG, Wolff JA, (2002) The effect of cell division on the cellular dynamics of microinjected DNA and dextran. Mol Ther 5: 579-588. doi:10.1006/mthe.2002.0581. PubMed: 11991749.
36. Dean DA, Byrd JN, Dean BS, (1999) Nuclear targeting of plasmid DNA in human corneal cells. Curr Eye Res 19: 66-75. doi:10.1076/ceyr.19.1.66.5344. PubMed: 10415459.
37. Escriou V, Ciolina C, Helbling-Leclerc A, Wils P, Scherman D, (1998) Cationic lipid-mediated gene transfer: analysis of cellular uptake and nuclear import of plasmid DNA. Cell Biol Toxicol 14: 95-104. doi:10.1023/A:1007425803756. PubMed: 9553720.
38. Lechardeur D, Sohn KJ, Haardt M, Joshi PB, Monck M, et al. (1999) Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther 6: 482-497. doi:10.1038/sj.gt.3300867. PubMed: 10476208.
39. Zelphati O, Liang X, Hobart P, Felgner PL, (1999) Gene chemistry: functionally and conformationally intact fluorescent plasmid DNA. Hum Gene Ther 10: 15-24. doi:10.1089/10430349950019156. PubMed: 10022527.
40. Pollard H, Toumaniantz G, Amos JL, Avet-Loiseau H, Guihard G, et al. (2001) Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids. J Gene Med 3: 153-164. doi:10.1002/jgm.160. PubMed: 11318114.
41. Banks GA, Roselli RJ, Chen R, Giorgio TD, (2003) A model for the analysis of nonviral gene therapy. Gene Ther 10: 1766-1775. doi:10.1038/sj.gt.3302076. PubMed: 12939643.